ANL
Price
$1.47
Change
-$0.03 (-2.00%)
Updated
Jun 18 closing price
Capitalization
54.24M
48 days until earnings call
VCEL
Price
$41.78
Change
+$0.28 (+0.67%)
Updated
Jun 18 closing price
Capitalization
2.1B
40 days until earnings call
Interact to see
Advertisement

ANL vs VCEL

Header iconANL vs VCEL Comparison
Open Charts ANL vs VCELBanner chart's image
Adlai Nortye
Price$1.47
Change-$0.03 (-2.00%)
Volume$16.71K
Capitalization54.24M
Vericel
Price$41.78
Change+$0.28 (+0.67%)
Volume$404.54K
Capitalization2.1B
ANL vs VCEL Comparison Chart in %
Loading...
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANL vs. VCEL commentary
Jun 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a Hold and VCEL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2025
Stock price -- (ANL: $1.47 vs. VCEL: $41.78)
Brand notoriety: ANL and VCEL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 81% vs. VCEL: 82%
Market capitalization -- ANL: $54.24M vs. VCEL: $2.1B
ANL [@Biotechnology] is valued at $54.24M. VCEL’s [@Biotechnology] market capitalization is $2.1B. The market cap for tickers in the [@Biotechnology] industry ranges from $335.78B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 0 FA rating(s) are green whileVCEL’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 0 green, 5 red.
  • VCEL’s FA Score: 0 green, 5 red.
According to our system of comparison, ANL is a better buy in the long-term than VCEL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

VCEL’s TA Score shows that 5 TA indicator(s) are bullish.

  • VCEL’s TA Score: 5 bullish, 5 bearish.

Price Growth

ANL (@Biotechnology) experienced а -11.98% price change this week, while VCEL (@Biotechnology) price change was -5.43% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.32%. For the same industry, the average monthly price growth was +13.75%, and the average quarterly price growth was +8.90%.

Reported Earning Dates

ANL is expected to report earnings on Aug 07, 2025.

VCEL is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Biotechnology (+7.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCEL($2.1B) has a higher market cap than ANL($54.2M). VCEL YTD gains are higher at: -23.912 vs. ANL (-45.255). VCEL has higher annual earnings (EBITDA): 10.6M vs. ANL (-49.89M). VCEL has more cash in the bank: 113M vs. ANL (98M). ANL has less debt than VCEL: ANL (39.5M) vs VCEL (99M). VCEL has higher revenues than ANL: VCEL (239M) vs ANL (5M).
ANLVCELANL / VCEL
Capitalization54.2M2.1B3%
EBITDA-49.89M10.6M-471%
Gain YTD-45.255-23.912189%
P/E RatioN/A835.60-
Revenue5M239M2%
Total Cash98M113M87%
Total Debt39.5M99M40%
FUNDAMENTALS RATINGS
VCEL: Fundamental Ratings
VCEL
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
59
SMR RATING
1..100
88
PRICE GROWTH RATING
1..100
78
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
VCEL
RSI
ODDS (%)
Bearish Trend 2 days ago
73%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
79%
MACD
ODDS (%)
Bearish Trend 2 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
70%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 3 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
VCEL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CUSRX12.210.11
+0.91%
Cullen Small Cap Value Retail
NCGFX64.18-0.01
-0.02%
New Covenant Growth
HCACX24.31-0.02
-0.08%
Hartford Capital Appreciation C
MXEOX10.09-0.02
-0.20%
Empower Emerging Markets Equity Inv
MGFSX10.11-0.04
-0.39%
MassMutual Global R5

ANL and

Correlation & Price change

A.I.dvisor tells us that ANL and RIGL have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ANL and RIGL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
-2.00%
RIGL - ANL
25%
Poorly correlated
+1.04%
FGHQF - ANL
25%
Poorly correlated
N/A
LENZ - ANL
22%
Poorly correlated
+3.69%
NVCT - ANL
21%
Poorly correlated
-0.74%
VCEL - ANL
21%
Poorly correlated
+0.67%
More